These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116 [TBL] [Abstract][Full Text] [Related]
45. Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Berrebi A; Bardou M; Bessieres MH; Nowakowska D; Castagno R; Rolland M; Wallon M; Franck J; Bongain A; Monnier-Barbarino P; Assouline C; Cassaing S Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):53-7. PubMed ID: 17189666 [TBL] [Abstract][Full Text] [Related]
46. Radiology casebook. Congenital toxoplasmosis: a case report. Pan J; Carey BE J Perinatol; 1998; 18(6 Pt 1):489-91. PubMed ID: 9848769 [No Abstract] [Full Text] [Related]
47. Diagnosis and management of toxoplasmosis. Montoya JG; Rosso F Clin Perinatol; 2005 Sep; 32(3):705-26. PubMed ID: 16085028 [TBL] [Abstract][Full Text] [Related]
48. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination]. Couvreur J Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148 [No Abstract] [Full Text] [Related]
49. Delayed onset of severe neonatal toxoplasmosis. Al-Hamod D; Vauloup C; Goulet M; Zupan-Simunek V; Castel C; Boileau P J Perinatol; 2010 Mar; 30(3):231-2. PubMed ID: 20182429 [TBL] [Abstract][Full Text] [Related]
50. Fetal therapy of severe symptomatic toxoplasmosis using azithromycin. Tamaru S; Kikuchi A; Takagi K; Wakamatsu M; Horikoshi T; Ogiso Y J Obstet Gynaecol Res; 2011 Jul; 37(7):953-7. PubMed ID: 21450026 [TBL] [Abstract][Full Text] [Related]
51. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. McAuley J; Boyer KM; Patel D; Mets M; Swisher C; Roizen N; Wolters C; Stein L; Stein M; Schey W Clin Infect Dis; 1994 Jan; 18(1):38-72. PubMed ID: 8054436 [TBL] [Abstract][Full Text] [Related]
52. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Petersen E; Schmidt DR Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110 [TBL] [Abstract][Full Text] [Related]
53. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Gras L; Gilbert RE; Ades AE; Dunn DT Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335 [TBL] [Abstract][Full Text] [Related]
54. Fetal cataract in congenital toxoplasmosis. Pedreira DA; Diniz EM; Schultz R; Faro LB; Zugaib M Ultrasound Obstet Gynecol; 1999 Apr; 13(4):266-7. PubMed ID: 10341406 [TBL] [Abstract][Full Text] [Related]